CAH - Cardinal Health Inc - SEC Form 4 Insider Trading Screener

Retail Trade - Nondurable Goods - Wholesale-drugs, Proprietaries & Druggists' Sundries - - CAH (721371)
General
Tickers
Insider
Date
Filing Date
  
Trade Date
  
Transaction Code
P - Purchase
S - Sale
A - Grant
D - Sale to Issuer
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Traded K$
Own Chg %
Share Price $
Liquidity M$
Filing Delay
Group by
Sort by
Max Results
N Days Ago
Multiple Days
No deriv clear
100 results for CAH - Yahoo - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P2+0+1-2+14
S98+0+1+2+15

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2016-05-20
CAHWatkins Carole SCHROS - Sale+OE$77.33-84,61733,994-71%-$6,543,433+1+2
D
2015-11-10
CAHBarrett George SCOB, CEOS - Sale+OE$87.73-54,658406,134-12%-$4,795,146-2+2-20
D
2015-11-06
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$87.66-30,08533,633-47%-$2,637,2510-200
D
2015-08-20
CAHBarrett George SCOB, CEOS - Sale+OE$83.08-300,000406,134-42%-$24,924,000-5+2+10
2015-08-06
CAHAnderson David JDirP - Purchase$86.41+1,4003,428+69%+$120,974+1-1-5-9
D
2015-05-12
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$86.12-39,42829,061-58%-$3,395,539+1+1+4+3
D
2015-05-11
CAHBarrett George SCOB, CEOS - Sale+OE$86.44-300,000348,694-46%-$25,932,000+1+1+4+3
D
2015-05-08
CAHMorrison PatriciaCIOS - Sale+OE$86.22-36,04230,797-54%-$3,107,541+1+1+4+3
D
2015-03-03
CAHDarden CalvinDirS - Sale+OE$87.85-9,80122,771-30%-$861,0180-2+1-9
D
2015-03-03
CAHNotebaert Richard CDirS - Sale+OE$88.20-9,80135,778-22%-$864,4480-2+1-9
D
2015-03-04
CAHArnold Colleen F.DirS - Sale+OE$87.65-9,80121,597-31%-$859,0580-2+1-9
D
2015-02-20
CAHWatkins Carole SCHROS - Sale+OE$87.00-33,84731,868-52%-$2,944,6890+2+2-8
D
2015-02-10
CAHWatkins Carole SCHROS - Sale+OE$85.00-50,77031,870-61%-$4,315,450+1+1+4+2
D
2015-02-10
CAHBarrett George SCOB, CEOS - Sale+OE$84.87-300,000348,694-46%-$25,461,000+1+1+4+2
D
2014-11-07
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale+OE$79.50-24,66820,409-55%-$1,961,106+1+2+3+10
D
2014-09-05
CAHWatkins Carole SCHROS - Sale+OE$75.00-40,79431,936-56%-$3,059,55000+1+18
D
2014-09-04
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$74.95-50,216118,576-30%-$3,763,689+1+1+3+18
D
2014-08-27
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$72.63-26,56767,190-28%-$1,929,561+1+1+3+21
2014-08-25
CAHKing David PDirS - Sale$73.55-3012,0980%-$2,207-1+1+6+21
D
2014-08-18
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale+OE$72.15-4,78222,589-17%-$345,0210+1+3+20
D
2014-08-18
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$72.06-78,63767,190-54%-$5,666,5820+1+3+20
D
2014-08-18
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$72.06-6,833118,576-5%-$492,3860+1+3+20
D
2014-08-08
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$69.72-118,09373,004-62%-$8,233,44400+6+19
D
2014-08-08
CAHMorford Craig SChief Legal, Compliance OfficeS - Sale+OE$70.03-43,35968,762-39%-$3,036,43100+6+19
D
2014-07-24
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale+OE$72.50-21,2665,776-79%-$1,541,78500+2+18
D
2014-07-24
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale+OE$73.41-23,11424,416-49%-$1,696,79900+2+18
2014-07-14
CAHHenderson Jeffrey WilliamCFOS - Sale$70.65-23,63283,464-22%-$1,669,6010-10+18
2014-05-19
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale$66.50-4,70324,416-16%-$312,750+2+4+4+22
D
2014-05-12
CAHBarrett George SCOB, CEOS - Sale+OE$65.04-8,416334,102-2%-$547,3770+1+4+22
2014-05-13
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale$66.50-2,82229,119-9%-$187,6630+1+4+22
2014-05-07
CAHHenderson Jeffrey WilliamCFOS - Sale$63.83-27,031107,096-20%-$1,725,389+1+2+11+26
D
2014-02-10
CAHBarrett George SCOB, CEOS - Sale+OE$66.64-200,000334,102-37%-$13,328,0950+2+4+3
2014-02-07
CAHWatkins Carole SCHROS - Sale$67.01-28,26027,619-51%-$1,893,7030+2+4+4
DM
2014-02-10
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$67.46-388,995115,969-77%-$26,242,4970+2+4+3
2014-02-11
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale$68.53-2,33031,941-7%-$159,6750+2+4+3
D
2014-02-04
CAHNotebaert Richard CDirS - Sale+OE$65.68-10,72733,750-24%-$704,549+1+6+11+9
D
2014-02-05
CAHKenny Gregory BDirS - Sale+OE$65.39-18,17519,584-48%-$1,188,463+1+6+11+9
D
2014-02-04
CAHFinn John FDirS - Sale+OE$65.68-10,72743,982-20%-$704,549+1+6+11+9
D
2014-02-05
CAHDarden CalvinDirS - Sale+OE$65.43-5,28220,743-20%-$345,601+1+6+11+9
D
2014-02-04
CAHArnold Colleen F.DirS - Sale+OE$65.46-8,27019,569-30%-$541,354+1+6+11+9
D
2014-02-04
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$65.56-17,92624,239-43%-$1,175,229+1+6+11+9
D
2014-02-04
CAHWatkins Carole SCHROS - Sale+OE$65.71-46,66655,873-46%-$3,066,423+1+6+11+9
D
2014-02-03
CAHMorford Craig SChief Legal, Compliance OfficeS - Sale+OE$66.95-27,29568,387-29%-$1,827,400+1+6+11+9
D
2014-02-03
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$67.19-253,190134,127-65%-$17,011,836+1+6+11+9
D
2013-11-11
CAHBarrett George SCOB, CEOS - Sale+OE$62.71-200,000334,102-37%-$12,542,000+2+3+5+5
D
2013-09-30
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale+OE$52.01-24,8795,776-81%-$1,293,9570+2+6+33
D
2013-09-11
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale+OE$51.53-14,58434,271-30%-$751,5140+1+4+39
2013-08-19
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale$51.27-4,92530,641-14%-$252,505-20+4+40
D
2013-08-15
CAHMorford Craig SChief Legal, Compliance OfficeS - Sale+OE$51.33-20,00081,554-20%-$1,026,60000+5+40
D
2013-08-16
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$51.50-10,00034,239-23%-$515,00000+5+40
D
2013-08-13
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$51.99-54,590167,390-25%-$2,838,1340-2+3+37
2013-08-13
CAHBarrett George SCOB, CEOS - Sale$52.09-75,000325,787-19%-$3,906,7500-2+3+37
D
2013-08-08
CAHDarden CalvinDirS - Sale+OE$51.48-3,25418,131-15%-$167,516+10-1+31
D
2013-08-05
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale+OE$51.53-29,16632,741-47%-$1,502,924+1+2-2+29
D
2013-07-26
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$50.99-76,781155,084-33%-$3,915,063-1+1+1+30
D
2013-07-18
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$49.99-57,623131,865-30%-$2,880,574-1+1+1+35
D
2013-07-15
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$49.99-14,660131,109-10%-$732,853+1+1+5+39
D
2013-07-11
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$48.99-83,211130,916-39%-$4,076,507-1+2+4+41
D
2013-06-19
CAHFinn John FDirS - Sale+OE$48.51-11,07043,290-20%-$537,0370+2+8+40
DM
2013-05-24
CAHSpaulding Jean GDirS - Sale+OE$47.35-8,35017,182-33%-$395,414+1-2+1+39
D
2013-05-22
CAHNotebaert Richard CDirS - Sale+OE$48.10-3,19731,138-9%-$153,776-10-1+38
2013-05-22
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale$47.52-36104,3300%-$1,711-10-1+38
D
2013-05-20
CAHWatkins Carole SCHROS - Sale+OE$48.00-4,61249,763-8%-$221,376-1-1+1+37
D
2013-05-20
CAHMorford Craig SChief Legal, Compliance OfficeS - Sale+OE$48.00-45,99495,330-33%-$2,207,712-1-1+1+37
2013-05-20
CAHSpaulding Jean GDirS - Sale$47.90-1,66616,996-9%-$79,801-1-1+1+37
2013-05-14
CAHCox Carrie SmithDirP - Purchase$46.25+43514,129+3%+$20,1190+3+2+37
D
2013-05-07
CAHWatkins Carole SCHROS - Sale+OE$45.95-25,59247,882-35%-$1,175,952-10-1+35
D
2013-05-07
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale+OE$46.00-30,82525,480-55%-$1,417,950-10-1+35
2013-05-06
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale$46.14-14,25339,577-26%-$657,633-10-1+35
DM
2013-05-07
CAHMorford Craig SChief Legal, Compliance OfficeS - Sale+OE$46.12-48,14080,883-37%-$2,220,458-10-1+35
D
2013-05-06
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$46.18-207,918107,284-66%-$9,601,653-10-1+35
D
2013-05-06
CAHNotebaert Richard CDirS - Sale+OE$46.25-5,00131,081-14%-$231,296-10-1+35
D
2013-05-06
CAHSpaulding Jean GDirS - Sale+OE$46.19-10,44718,662-36%-$482,547-10-1+35
D
2013-01-23
CAHMorford Craig SChief Legal, Compliance OfficeS - Sale+OE$45.00-47,27470,088-40%-$2,127,3300-2+1+12
D
2013-01-23
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$44.95-58,362104,362-36%-$2,623,3720-2+1+12
D
2013-01-23
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$45.00-39,08053,830-42%-$1,758,6000-2+1+12
D
2013-01-10
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$43.00-39,86742,945-48%-$1,714,281+1+3+5+17
2013-01-10
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale$42.92-1,47117,955-8%-$63,135+1+3+5+17
2012-12-14
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale$42.25-2,33019,426-11%-$98,443+1-1+4+17
2012-11-01
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale$41.22-2,5645,150-33%-$105,688-1-3-2+15
D
2012-10-04
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$40.00-46,226109,910-30%-$1,849,0400+2-2+7
DM
2012-09-07
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$38.32-79,410110,279-42%-$3,043,171-10+8+25
D
2012-05-17
CAHSpaulding Jean GDirS - Sale+OE$42.06-8,13515,406-35%-$342,1580+1+3-3
D
2012-02-27
CAHLynch Michael ACEO, Medical SegmentS - Sale+OE$42.00-31,37389,204-26%-$1,317,666-1-2+2-4
D
2012-02-24
CAHLynch Michael ACEO, Medical SegmentS - Sale+OE$41.59-40,17381,177-33%-$1,670,7950-2+3-5
DM
2011-10-26
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$44.95-43,16490,678-32%-$1,940,222-3-3-9-6
2011-10-19
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale$42.40-1,3416,393-17%-$56,858+4+40-1
2011-09-14
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale$41.14-1,1917,734-13%-$48,998+4+3+1+2
D
2011-08-17
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale+OE$41.73-1,1009,230-11%-$45,903-4-2-10
2011-07-13
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale$46.68-1,1009,087-11%-$51,3480-1-12-9
D
2011-07-07
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$47.00-11,12124,513-31%-$522,687-2-1-14-12
2011-07-06
CAHFinn John FDirS - Sale$46.50-2,86438,561-7%-$133,176-2-1-14-12
D
2011-07-01
CAHWatkins Carole SCHROS - Sale+OE$46.00-6,69859,358-10%-$308,108+1-1-9-12
D
2011-07-01
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$45.95-10,14362,192-14%-$466,071+1-1-9-12
2011-06-15
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale$43.79-1,10010,187-10%-$48,169+1+2+7-5
D
2011-05-19
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$45.25-57,854112,053-34%-$2,617,894-20-2-4
2011-05-11
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale$44.96-1,02511,287-8%-$46,0840+1-3-4
D
2011-05-05
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$45.00-6,95422,017-24%-$312,930+20-10
D
2011-05-05
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$44.95-10,14362,192-14%-$455,928+20-10
D
2011-04-27
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$43.95-10,14362,192-14%-$445,785-1+1+2+1
A Amended filing (a previous filing had an error)
D Derivative transaction exists (usually option exercise)
E Error filing (OpenInsider detected an error in the filing)
M Multiple insider transactions summarized; earliest reported transaction date and weighted average transaction price
Open: Yahoo - Finviz - Stockcharts - Google

Return to top
S - SaleSale of securities on an exchange or to another person
S - Sale on exerciseSale of securities on an exchange or to another person (after option exercise)
F - OptEx/tax paymentPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person